{"AllianceGenome": "3395", "HGNC": "3395", "MIM": "600011", "_id": "2050", "_version": 1, "accession": {"genomic": ["AC011895.4", "AF312032.1", "AY056047.1", "CH236956.1", "CH471091.2", "CP068271.2", "GM868979.1", "NC_000007.14", "NC_060931.1", "NG_052671.1"], "protein": ["AAA20598.1", "AAH04264.1", "AAH52804.1", "AAK21010.1", "AAL14194.1", "AAL14195.1", "ACF47644.1", "ACF47645.1", "ACF47646.1", "BAD92881.1", "BAG62797.1", "CAT16953.1", "EAL23820.1", "EAW76468.1", "EAW76469.1", "EAW76470.1", "NP_004435.3", "P54760.2", "XP_016867305.1", "XP_054213436.1"], "rna": ["AB209644.1", "AK301224.1", "AY056048.1", "BC004264.1", "BC052804.1", "CB962032.1", "EU826608.1", "EU826609.1", "EU826610.1", "NM_004444.5", "U07695.1", "XM_017011816.2", "XM_054357461.1"], "translation": [{"protein": "BAG62797.1", "rna": "AK301224.1"}, {"protein": "XP_016867305.1", "rna": "XM_017011816.2"}, {"protein": "ACF47646.1", "rna": "EU826610.1"}, {"protein": "ACF47644.1", "rna": "EU826608.1"}, {"protein": "AAH04264.1", "rna": "BC004264.1"}, {"protein": "AAA20598.1", "rna": "U07695.1"}, {"protein": "XP_054213436.1", "rna": "XM_054357461.1"}, {"protein": "NP_004435.3", "rna": "NM_004444.5"}, {"protein": "ACF47645.1", "rna": "EU826609.1"}, {"protein": "AAL14195.1", "rna": "AY056048.1"}, {"protein": "AAH52804.1", "rna": "BC052804.1"}, {"protein": "BAD92881.1", "rna": "AB209644.1"}]}, "alias": ["CMAVM2", "HFASD", "HTK", "LMPHM7", "MYK1", "TYRO11"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2022-11-03T16:00:00.000Z", "disease_label": "EPHB4-associated vascular malformation spectrum", "gcep": "Prenatal Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0700080", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_d1a3438a-72a7-41f7-b140-2041ea7a39c1-2022-11-03T160000.000Z", "sop": "SOP9"}}, "ec": "2.7.10.1", "ensembl": {"gene": "ENSG00000196411", "protein": ["ENSP00000350896", "ENSP00000353833", "ENSP00000482702"], "transcript": ["ENST00000358173", "ENST00000360620", "ENST00000467515", "ENST00000477446", "ENST00000478459", "ENST00000487222", "ENST00000489808", "ENST00000492403", "ENST00000492878", "ENST00000616502"], "translation": [{"protein": "ENSP00000353833", "rna": "ENST00000360620"}, {"protein": "ENSP00000482702", "rna": "ENST00000616502"}, {"protein": "ENSP00000350896", "rna": "ENST00000358173"}], "type_of_gene": "protein_coding"}, "entrezgene": "2050", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 35.5702538001, "exp_mis": 444.220340975, "exp_syn": 209.182690084, "lof_z": 5.07744549001179, "mis_z": 2.83635499060531, "mu_lof": 2.86656851409e-06, "mu_mis": 4.30165058566e-05, "mu_syn": 2.0055371116e-05, "n_lof": 5.0, "n_mis": 322.0, "n_syn": 225.0, "p_li": 0.989869332436591, "p_null": 1.02397516390408e-09, "p_rec": 0.0101306665394343, "syn_z": -0.677983093062006}, "bp": 2964, "cds_end": 100424652, "cds_start": 100401082, "n_exons": 17, "nonpsych": {"exp_lof": 31.8801060981, "exp_mis": 401.747880257, "exp_syn": 189.016120376, "lof_z": 4.67544584357955, "mis_z": 2.7617293116837, "mu_lof": 2.86656851409e-06, "mu_mis": 4.30165058566e-05, "mu_syn": 2.0055371116e-05, "n_lof": 5.0, "n_mis": 292.0, "n_syn": 208.0, "p_li": 0.965695766766669, "p_null": 2.52442732133699e-08, "p_rec": 0.0343042079890579, "syn_z": -0.869359802378589}, "transcript": "ENST00000358173.3"}, "exons": [{"cdsend": 100827030, "cdsstart": 100803460, "chr": "7", "position": [[100802564, 100803590], [100805165, 100805321], [100805500, 100805694], [100806419, 100806569], [100807364, 100807580], [100812746, 100812994], [100813094, 100813208], [100813651, 100813716], [100813918, 100814021], [100817191, 100817357], [100818519, 100818644], [100819556, 100819889], [100820140, 100820296], [100822270, 100822667], [100823643, 100823931], [100824202, 100824273], [100826978, 100827523]], "strand": -1, "transcript": "NM_004444", "txend": 100827523, "txstart": 100802564}], "exons_hg19": [{"cdsend": 100424652, "cdsstart": 100401082, "chr": "7", "position": [[100400186, 100401212], [100402787, 100402943], [100403122, 100403316], [100404041, 100404191], [100404986, 100405202], [100410368, 100410616], [100410716, 100410830], [100411273, 100411338], [100411540, 100411643], [100414813, 100414979], [100416141, 100416266], [100417178, 100417511], [100417762, 100417918], [100419892, 100420289], [100421265, 100421553], [100421824, 100421895], [100424600, 100425145]], "strand": -1, "transcript": "NM_004444", "txend": 100425145, "txstart": 100400186}], "generif": [{"pubmed": 11929761, "text": "accelerates differentiation of select human hematopoietic cells"}, {"pubmed": 12051776, "text": "role of EphB4 receptor in erythropoiesis"}, {"pubmed": 12235151, "text": "Eph B4 stimulates migration and proliferation and may play a role in angiogenesis"}, {"pubmed": 12734395, "text": "EphB4 is pro-adhesive and stimulates endothelial cell migration and sprouting angiogenesis. EphrinB2-mediated repulsive signals are transduced by EphB4."}, {"pubmed": 14764452, "text": "HoxA9 binds to the EphB4 promoter & stimulates its expression resulting in an increase of endothelial cell migration and tube forming activity. Thus, modulation of EphB4 expression may contribute to the proangiogenic effect of HoxA9 in endothelial cells."}, {"pubmed": 15126321, "text": "in hyperinflammatory lesions, ephrinB2 was predominantly expressed in macrophage-like cells and EphB4 in small venules; syntenin and syndecan-1 were up-regulated in EphB4-positive endothelial cells after stimulation with preclustered ephrinB2"}, {"pubmed": 15193868, "text": "EphB4 and ephrin-B2 molecules, which have specific expression patterns during artery and vein development, respectively, were expressed in the placenta"}, {"pubmed": 15358160, "text": "These results suggest that activation of EphB4 participates in adhesive but not repulsive signals independently of its tyrosine kinase activity in hematopoietic cells."}, {"pubmed": 15722342, "text": "analysis of EphB1, EphB2, and EphB4-binding peptides interaction with antagonists with ephrin-like affinity"}, {"pubmed": 15930280, "text": "EphB4 protein levels are high in the PC3 prostate cancer cell line and several folds higher in a metastatic clone of PC3 (PC3M) where overexpression was accompanied by EphB4 gene amplification."}, {"pubmed": 16107476, "text": "EPHB4 regulates chemokine-evoked trophoblast responses: a mechanism for incorporating the human placenta into the maternal circulation."}, {"pubmed": 16171530, "text": "EphB4 is expressed in prostate cancer cell lines with increased expression in human prostate cancers when compared with matched normal tissue"}, {"pubmed": 16205642, "text": "EphB4 knockdown in an in vivo murine tumor xenograft model led to a nearly 80% reduction in tumor volume associated with reduced tumor proliferation, increased apoptosis and reduced tumor microvasculature"}, {"pubmed": 16343615, "text": "EphB4 and ephrin-B2 are instrumental in the establishment of a functional placental structure and of the utero-placental circulation."}, {"pubmed": 16424904, "text": "EphB4 acts as a negative regulator of blood vessel branching and vascular network formation, switching the vascularization program from sprouting angiogenesis to circumferential vessel growth."}, {"pubmed": 16615113, "text": "Overexpression of EphB4 is associated with squamous cell carcinoma of the head and neck"}, {"pubmed": 16840724, "text": "novel link between EphB forward signaling and SDF-1-induced signaling demonstrates a mechanism for cooperative regulation of endothelial cell movement."}, {"pubmed": 16867992, "text": "The results provide critical information on the EphB4*ephrinB2 protein interfaces and their mode of interaction, which will facilitate development of small molecule compounds inhibiting the EphB4*ephrinB2 interaction as novel cancer therapeutics."}, {"pubmed": 16982731, "text": "Study provides evidence showing that promoter methylation regulates EPHB4 transcription and that EPHB4 can regulate the long-term clonogenic potential of colorectal tumor cells, revealing EPHB4 as a potential tumor suppressor gene in colorectal cancer."}, {"pubmed": 17196593, "text": "demonstrates that Eph B4 and Ephrin B2 interaction may play an important role in the oncogenesis and angiogenesis of cervical carcinomas"}, {"pubmed": 17234965, "text": "Notch signaling by induction of Dll1 was necessary & sufficient to induce EphB4-dependent branching morphogenesis in human arterial EC."}, {"pubmed": 17353927, "text": "Overexpression of EphB4 is associated with ovarian cancer"}, {"pubmed": 17510705, "text": "activation of EphB4 enhances proangiogenic capacity through induction of PSGL-1 expression and adhesion to E selectin and P selectin"}, {"pubmed": 17611172, "text": "EphB4 expression was found in 44 (72.1%) out of 61 cancer tissues analysed."}, {"pubmed": 18231102, "text": "Overexpression of EphB4 is associated with tumour advancement of ovarian cancers"}, {"pubmed": 18340006, "text": "EphB4 is a critical component of the CYP2C9- and 11,12-EET-activated signaling cascade that promotes angiogenesis in vitro as well as in vivo."}, {"pubmed": 18957513, "text": "EphBR-ephrinB interactions lead to monocyte adhesion and transmigration through the vascular endothelium."}, {"pubmed": 19035475, "text": "EphB4 receptor activation by ephrin B2 in osteoarthritis subchondral bone could affect abnormal metabolism in this tissue by inhibiting resorption factors and their activities"}, {"pubmed": 19272799, "text": "High EphB4 is associated with malignant urogenital tissue."}, {"pubmed": 19356789, "text": "Localization of EphB4 is dominantly in the cancer cells of uterine cervical cancers of all cases given."}, {"pubmed": 19366806, "text": "EphB4 is preferentially induced in colorectal cancer, in contrast to EphB2, whereby tumor cells acquire a survival advantage."}, {"pubmed": 19552627, "text": "The findings demonstrate that EphB4 can affect cancer cell behaviour in an ephrin-independent manner."}, {"pubmed": 19597185, "text": "the ephrinB2/EphB4 axis is dysregulated in multiple myeloma, and its activation by EphB4-Fc inhibits myeloma growth and bone disease"}, {"pubmed": 19664212, "text": "Our study is the first to provide data on the presence and role of ephrin B2/EphB4 receptors in human chondrocytes/cartilage"}, {"pubmed": 20002159, "text": "EphB4 mediates a new mechanism of imatinib resistance that is independent of BCR-ABL and dependent on the RAS/MAPK pathway."}, {"pubmed": 20031623, "text": "EPHB4 gene polymorphisms are associated with the risk of intracranial hemorrhage in patients with brain arteriovenous malformations."}, {"pubmed": 20031623, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20061560, "text": "EPHB4 can function as a tumor suppressor in acute lymphoblastic leukemia"}, {"pubmed": 20133814, "text": "MAb47 targets fibronectin-like domain 2 of both human and murine EphB4 and does not alter EphB4 receptor levels, but inhibits angiogenesis and growth of both EphB4-positive and EphB4-negative tumors in a mouse s.c. xenograft model"}, {"pubmed": 20686847, "text": "Ephb4 was over-expressed and localized to the cytoplasm of gastric cancer cells. Moreover, Ephb4 protein was observed as being significantly related to tumor size and regional lymph nodes category."}, {"pubmed": 21047731, "text": "EphB4/ephrinB2 interactions between tumor cells and endothelial cells identify a mechanism for site-specific metastatic dissemination of tumor cells."}, {"pubmed": 21575518, "text": "The expressions of ephrinB2 and EphB4 were significantly higher in NSCLC tissue than in control tissues, and were positively correlated with lymphatic metastasis."}, {"pubmed": 21935409, "text": "Data found significant correlations between ephA2, ephA4, ephA7, ephB4, and ephB6 and overall and/or recurrence-free survival in large microarray datasets."}, {"pubmed": 22024229, "text": "EphB4/EphrinB2 expression has closed related to gennesis and progression of hepatoblastoma."}, {"pubmed": 22374425, "text": "Data indicated for the first time that EphrinB2 and EphB4 expressions increase according to the histopathological grade and KPS score of glioma, and their expression levels are related to the progression-free survival of glioblastoma patients."}, {"pubmed": 22528941, "text": "EphB4 plays an important role in the progression of papillary thyroid carcinoma by stimulating cell migration and EphB4 might be a potential therapeutic target in papillary thyroid carcinoma."}, {"pubmed": 22684558, "text": "levels of EphB4, mTOR and Akt were distinctly lower than those in other groups. It was concluded that suppression of EphB4 may inhibit the growth of ovarian cancer cells by downregulation of the PI3K/Akt/mTOR pathway."}, {"pubmed": 22684742, "text": "EphB4 protein expression is significantly increased in non-small- cell lung cancer and corresponds to progression and severity of the disease."}, {"pubmed": 23063927, "text": "verify amplification and/or deletion in the ACHE, BCHE, EPHB4 and MME genes in 32 samples of sporadic breast cancer"}, {"pubmed": 23079712, "text": "EphB4 receptor expresion is correlated to the initiation, progression and tumor angiogenesis."}, {"pubmed": 23100466, "text": "EphB4 is robustly expressed and potentially serves as a novel biomarker for targeted therapy in esophageal cancers"}, {"pubmed": 23138393, "text": "expression of EphB4 was significantly upregulated in clinical glioma samples; overexpression of EphB4 in glioma cell lines accelerated cell growth and tumorigenesis; downregulation of EphB4 inhibited cell growth"}, {"pubmed": 23211050, "text": "HAb47-Cy5.5 successfully imaged the decreased EphB4 expression."}, {"pubmed": 23295955, "text": "Data indicate that the reduced vimentin expression in response to EPHB4, WIPF2 and MTHFD2 silencing was observed at mRNA and protein levels."}, {"pubmed": 23314808, "text": "molecular classification of breast cancer is based upon the expression of ESR, PGR and HER2; the expression of EPOR, membrane receptor GPER and EPHB4 may be considered as an additional classification factor in breast cancer"}, {"pubmed": 23579861, "text": "Compared gene expression profiles in CRC patients treated with bevacizumab who responded to the treatment with those that did not respond. Found EPHB4 expression significantly increased in nonresponders and high levels associated with decreased survival."}, {"pubmed": 23721559, "text": "EphB4 was overexpressed in 72% of mesothelioma tissues"}, {"pubmed": 23725356, "text": "Our data suggests EphB4 as an upstream regulator of ER-alpha in human breast cancer cells by modulating ER-alpha transcription. The results also suggest Akt as a relevant downstream signaling molecule in this novel EphB4-ER-alpha pathway."}, {"pubmed": 23844053, "text": "The EphB4 receptor tyrosine kinase promotes lung cancer growth."}, {"pubmed": 24121831, "text": "High EphB4 expression is associated with glioma."}, {"pubmed": 24427781, "text": "EphB4 activation can differentially inhibit breast cancer cells at post confluent state."}, {"pubmed": 24517927, "text": "EphB4 and ephrin B2 play important roles in neovascularization and arteriovenous differentiation/plasticity."}, {"pubmed": 24634162, "text": "These genes may be potential biomarkers for identification of subclinical lymph node involvement in papillary thyroid carcinoma (PTC)"}, {"pubmed": 24677421, "text": "Comparative crystalisation analysis of the human EphB family kinases has yielded new crystal forms of the human EphB2 and EphB4 catalytic domains."}, {"pubmed": 24733895, "text": "These results are the first to identify EphB4 and its cross-talk with PDGFRbeta as unexpected vital determinants of tumor cell survival in alveolar rhabdomyosarcoma."}, {"pubmed": 24764074, "text": "Decreased EphB4 expression is associated with acute myeloid leukemia."}, {"pubmed": 24771266, "text": "our study revealed the important function and regulation of EphB4 in the progression of ESCC and suggested EphB4 as a novel target for the treatment of ESCC."}, {"pubmed": 25051915, "text": "The recombinant plasmid can inhibit the expression of EphB4 mRNA and protein in PANC-1 cells, as well as cell growth and migration."}, {"pubmed": 25148033, "text": "loss of EphB2 and gain of EphB4 expression represents an inflection point in the development, growth and possibly progression of TCC."}, {"pubmed": 25191151, "text": "Venous Eph-B4 expression diminished (p = .002), Ephrin-B2 expression was not induced (p = .268), and expression of osteopontin (p = .002) was increased with exposure to arterial magnitudes of shear stress."}, {"pubmed": 25274141, "text": "Silencing of EPHB4 significantly reduced the transmigration of synovial sarcoma cells."}, {"pubmed": 25391996, "text": "EPHB4 expression is associate with progression of HNSCC from normal tissue to dysplasia and to cancer."}, {"pubmed": 25446283, "text": "Stimulation of Eph-B4 function may be a candidate strategy for translation to human clinical trials designed to inhibit venous neointimal hyperplasia."}, {"pubmed": 25581780, "text": "N-(2,4)-dinitrophenyl-L-arginine Interacts with EphB4 and Functions as an EphB4 Kinase Modulator."}, {"pubmed": 25724901, "text": "EphB4 contains two nuclear localization signal sequences and localises to the nucleus."}, {"pubmed": 25886373, "text": "EphB4 regulates integrin Beta8 expression and integrin Beta8 plays a role in prostate cancer cells."}, {"pubmed": 26033476, "text": "EphB4 facilitates stromal-mediated support of hematopoiesis in hematopoietic stem cells."}, {"pubmed": 26073592, "text": "Novel EPHB4 receptor tyrosine kinase mutations have been found in lung cancer patients."}, {"pubmed": 26132739, "text": "CTLA4 modification maintains EphB4 expression in mesenchymal stem cells under immune activation conditions."}, {"pubmed": 26191333, "text": "Suggest role for EphB4/IGF1R signaling in regulation proliferation/migration of breast cancer cells."}, {"pubmed": 26220827, "text": "Enhanced EphB4 expression was significantly associated with Thyroid Lesions."}, {"pubmed": 26414866, "text": "EPHB4 oncogenomic network provides a molecular basis for its role in tumor progression and points to EPHB4 as a potential tumor aggressiveness biomarker and drug target in gastroesophageal cancers"}, {"pubmed": 26481148, "text": "Results indicate EphB4 receptor as a critical mediator of erythropoietin-induced tumor progression."}, {"pubmed": 27072105, "text": "EphB4 protein acts as a tumour promoter associated with proliferation, invasion, and angiogenesis, and may be used as a potential colorectal cancer (CRC) therapeutic target."}, {"pubmed": 27072235, "text": "LISA method may be considered rapid and sensitive enough to detect even low levels of total and phosphorylated EphB4 Cost-effectiveness of this method for the detection of differential expression of EphB4 proteins in clinics is also noticeable."}, {"pubmed": 27226777, "text": "Study illustrates that aberrant activation of EphB4/ephrinB2 may mediate chronic myeloid leukemia resistance involved in cytoskeletal proteins."}, {"pubmed": 27400125, "text": "EPHB4 is a critical regulator of early lymphatic vascular development; mutations in the gene can cause an autosomal dominant form of lymphatic-related hydrops fetalis that is associated with a high mortality rate"}, {"pubmed": 27553867, "text": "this study uncovered the character of EPHB4-regulating endothelial activation in the pathogenesis of preeclampsia"}, {"pubmed": 27827952, "text": "Survival analysis showed that the non-small cell lung carcinoma patients with enhanced expression of CK7, ELF3, EGFR, and EphB4 mRNA in peripheral blood leukocytes had poorer disease-free survival and overall survival than those without."}, {"pubmed": 28165374, "text": "both EphA2 and EphB4 show potential as target for image-guided colorectal cancer surgery, but EphB4 seems to have the best characteristics with respect to tumor/normal mucosa distribution."}, {"pubmed": 28292467, "text": "HOXA9 transcriptionally regulated EPHB4 expression to modulate trophoblasts migration and invasion, which may suggest a contribution of HOXA9-EPHB4 in the poor placentation in the pathogenesis of preeclampsia."}, {"pubmed": 28371279, "text": "The identified endothelial signalling pathway of CCM3-DLL4/Notch-EphB4-Erk1/2 may provide an insight into mechanism of CCM3-ablation-mediated angiogenesis."}, {"pubmed": 28687708, "text": "EPHB4 mutations were identified in patients with multifocal capillary malformation with arteriovenous malformations."}, {"pubmed": 28739744, "text": "The expression of EPHB4 was increased in gastric cancer and increased EPHB4 expression was correlated with poor survival. Knockdown of EPHB4 promoted adhesion and exerted diverse effects on migration of gastric cancer cells."}, {"pubmed": 28817624, "text": "Inhibition of EphB4 forward signaling using soluble EphB4 protein fused with murine serum albumin failed to affect eRMS model tumor progression, but did moderately slow progression in murine aRMS"}, {"pubmed": 29096333, "text": "EphB4 overexpression is associated with resistance to dasatinib in chronic myeloid leukemia."}, {"pubmed": 29368976, "text": "EphB4 expression is associated with colorectal cancer cell proliferation and vascularization."}, {"pubmed": 29444212, "text": "This study reported the identification of germline loss-of-function EPHB4 mutations in vein of Galen aneurysmal malformation."}, {"pubmed": 29462967, "text": "functional expression of EphB4 is considered a promising differentiating characteristic, preferentially determined by non-invasive in vivo imaging, which may improve personalized theranostics of malignant melanoma."}, {"pubmed": 29848571, "text": "Our findings underscore the importance of adopting rational drug combinations to enhance therapeutic effect. Our study documenting enhanced response of HNSCC to cetuximab-RT with EphB4-ephrin-B2 blockade has the potential to translate into the clinic to benefit this patient population"}, {"pubmed": 29905864, "text": "knock-in of EPHB4 mutation in HEK293T cells also induced mTORC1 activity. Our data demonstrate the pathogenicity of the identified EPHB4 mutation as a novel cause of Central conducting lymphatic anomaly and suggesting that ERK inhibitors may have therapeutic benefits in such patients with complex lymphatic anomalies"}, {"pubmed": 29987450, "text": "EphB4 overexpression leads to vascular resistance by altering vascular morphogenesis, pericyte coverage, and cellular proliferation/apoptosis in experimental SF126 glioma models."}, {"pubmed": 30138897, "text": "miR-454 promotes the proliferation and invasion of trophoblast cells by inhibiting EPHB4 expression."}, {"pubmed": 30476378, "text": "pre-incubation of HL60/ADM with 4 microg/ml EphrinB2-Fc protein for 30 min significantly sensitized tumor cell to Adriamycin treatment by reduction of tumor cell viability and induction of apoptosis (p<0.001), while there was no significant change in other groups (p>0.05)."}, {"pubmed": 30760892, "text": "we hypothesized that patients considered clinically suspicious for hereditary hemorrhagic telangiectasia(HTT) with no variant detected in an HHT gene (ENG, ACVRL1, or SMAD4) may have an EPHB4 variant...An EPHB4 variant was identified in ten unrelated cases. Seven cases had a pathogenic EPHB4 variant, including one with mosaicism. Three cases had an EPHB4 variant of uncertain significance."}, {"pubmed": 30776480, "text": "Data suggest that ephrin-B2-dependent EphB4 phosphorylation acts as an anchoring signal to reduce the malignancy by inhibiting Akt phosphorylation in the glioma core, whereas the scarcity of signaling in the tumor periphery promotes invasion into the surrounding brain."}, {"pubmed": 30839116, "text": "MicroRNA-652-3p promotes the proliferation and invasion of the trophoblast HTR-8/SVneo cell line by targeting homeobox A9 to modulate the expression of ephrin receptor B4"}, {"pubmed": 30894369, "text": "findings present EphB4-ephrin-B2 inhibition as an alternative to anti-PDL1 therapeutics that can be used in combination with radiation to induce an effective antitumor immune response in patients with HNSCC"}, {"pubmed": 31017515, "text": "EphrinB2/EphB4 signaling regulates the capacity of dental pulp stem cells to induce sprouting angiogenesis"}, {"pubmed": 31197068, "text": "Ephrin/Eph receptor interaction facilitates macrophage recognition of differentiating human erythroblasts."}, {"pubmed": 31270394, "text": "show that the regulation of EphB4 expression is linked to a competing post-translational modification of its carboxy-terminal tail via phosphorylation of its tyrosine 987 by the Insulin receptor isoform-A kinase-associated activity in response to the autocrine IGF-II stimuli"}, {"pubmed": 31427368, "text": "Results show that EPHB4 was the most prominently phosphorylated protein on VE-PTP inhibition among those VE-PTP targets. Further analysis revealed that EPHB4 forms a ternary complex with VE-PTP and TIE2 in endothelial cells."}, {"pubmed": 31638179, "text": "In vitro study in breast cancer cells indicated that EFNB2 expression was associated with a lower cell proliferation, migration and motility. Public datasets analysis confirmed that a high EFNB2 gene expression was associated with a longer recurrence-free survival, whereas a high EPHB4 expression indicated a poor prognosis, particularly for the group of patients whose tumors expressed EPHB4 in the absence of EFNB2."}, {"pubmed": 31641103, "text": "EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells."}, {"pubmed": 31810288, "text": "these findings shed new light on the human EphB4 promoter structure and regulation, suggesting mechanistic features conserved among Pol-II TATA-less genes phylogenetically shared from Drosophila to Human genomes."}, {"pubmed": 31898661, "text": "EphB4 overexpression in BV resistance-acquired ovarian tumors helped us know more about molecular mechanisms of resistance to anti-VEGF therapies"}, {"pubmed": 32184358, "text": "Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance."}, {"pubmed": 32286515, "text": "Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients."}, {"pubmed": 32336043, "text": "Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma."}, {"pubmed": 32407961, "text": "Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner."}, {"pubmed": 32567728, "text": "The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme."}, {"pubmed": 33082297, "text": "Hsa_circ_0081534 increases the proliferation and invasion of nasopharyngeal carcinoma cells through regulating the miR-508-5p/FN1 axis."}, {"pubmed": 33153234, "text": "The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts."}, {"pubmed": 33598934, "text": "The differential expression of EPHB4 and ephrin B2 in cutaneous squamous cell carcinoma according to the grade of tumor differentiation: a clinicopathological study."}, {"pubmed": 34231312, "text": "EPHB4 mutation causes adult and adolescent-onset primary lymphedema."}, {"pubmed": 34296545, "text": "Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion."}, {"pubmed": 34347982, "text": "Transcriptional and Post-Translational Control Mechanisms for EphB4 Expression in Physiology and Cancer Disease."}, {"pubmed": 34403370, "text": "Mutations in EPHB4 cause human venous valve aplasia."}, {"pubmed": 34445227, "text": "EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer."}, {"pubmed": 34491620, "text": "Assessing the association of common genetic variants in EPHB4 and RASA1 with phenotype severity in familial cerebral cavernous malformation."}, {"pubmed": 35163601, "text": "EphrinB2-EphB4 Signaling in Neurooncological Disease."}, {"pubmed": 36813543, "text": "Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with EPHB4 pathogenic variants."}, {"pubmed": 37507023, "text": "Diverse p120RasGAP interactions with doubly phosphorylated partners EphB4, p190RhoGAP, and Dok1."}, {"pubmed": 37909437, "text": "Biological Significance of EphB4 Expression in Cancer."}, {"pubmed": 38150042, "text": "Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology."}, {"pubmed": 38151336, "text": "SAM domain variants of EPHB4 associated with aberrant signaling are linked to lymphatic-related fetal hydrops and facial dysmorphology."}], "genomic_pos": {"chr": "7", "end": 100827523, "ensemblgene": "ENSG00000196411", "start": 100802565, "strand": -1}, "genomic_pos_hg19": {"chr": "7", "end": 100425121, "start": 100400187, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0002042", "pubmed": 12734395, "qualifier": "involved_in", "term": "cell migration involved in sprouting angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003007", "qualifier": "involved_in", "term": "heart morphogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007155", "pubmed": 12734395, "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007275", "qualifier": "involved_in", "term": "multicellular organism development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0033674", "qualifier": "involved_in", "term": "positive regulation of kinase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046777", "pubmed": 8188704, "qualifier": "involved_in", "term": "protein autophosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048013", "qualifier": "involved_in", "term": "ephrin receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0048013", "pubmed": 12734395, "qualifier": "involved_in", "term": "ephrin receptor signaling pathway"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 8188704, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043235", "qualifier": "part_of", "term": "receptor complex"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 23533145, "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004714", "qualifier": "enables", "term": "transmembrane receptor protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004714", "pubmed": 8188704, "qualifier": "enables", "term": "transmembrane receptor protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005003", "pubmed": [12734395, 15930280], "qualifier": "enables", "term": "ephrin receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16867992, 26481148, 28514442, 30578106, 35384245], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}]}, "homologene": {"genes": [[7955, 30688], [7955, 30691], [9544, 719320], [9598, 463610], [9606, 2050], [9615, 489830], [9913, 515756], [10090, 13846], [10116, 686310]], "id": 20939}, "interpro": [{"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "Ephrin receptor ligand binding domain", "id": "IPR001090", "short_desc": "Ephrin_rcpt_lig-bd_dom"}, {"desc": "Serine-threonine/tyrosine-protein kinase, catalytic domain", "id": "IPR001245", "short_desc": "Ser-Thr/Tyr_kinase_cat_dom"}, {"desc": "Tyrosine-protein kinase, receptor class V, conserved site", "id": "IPR001426", "short_desc": "Tyr_kinase_rcpt_V_CS"}, {"desc": "Sterile alpha motif domain", "id": "IPR001660", "short_desc": "SAM"}, {"desc": "Fibronectin type III", "id": "IPR003961", "short_desc": "FN3_dom"}, {"desc": "Tyrosine-protein kinase, active site", "id": "IPR008266", "short_desc": "Tyr_kinase_AS"}, {"desc": "Galactose-binding-like domain superfamily", "id": "IPR008979", "short_desc": "Galactose-bd-like_sf"}, {"desc": "Growth factor receptor cysteine-rich domain superfamily", "id": "IPR009030", "short_desc": "Growth_fac_rcpt_cys_sf"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Tyrosine-protein kinase ephrin type A/B receptor-like", "id": "IPR011641", "short_desc": "Tyr-kin_ephrin_A/B_rcpt-like"}, {"desc": "Sterile alpha motif/pointed domain superfamily", "id": "IPR013761", "short_desc": "SAM/pointed_sf"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Ephrin receptor type-A /type-B", "id": "IPR016257", "short_desc": "Tyr_kinase_ephrin_rcpt"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}, {"desc": "Tyrosine-protein kinase, catalytic domain", "id": "IPR020635", "short_desc": "Tyr_kinase_cat_dom"}, {"desc": "Ephrin receptor, transmembrane domain", "id": "IPR027936", "short_desc": "Eph_TM"}, {"desc": "Ephrin type-B receptor 4, ligand binding domain", "id": "IPR034290", "short_desc": "EphB4_rcpt_lig-bd"}, {"desc": "Fibronectin type III superfamily", "id": "IPR036116", "short_desc": "FN3_sf"}, {"desc": "EPH-B4, SAM domain", "id": "IPR037636", "short_desc": "EPH-B4_SAM"}], "ipi": ["IPI00186826", "IPI00289342"], "map_location": "7q22.1", "name": "EPH receptor B4", "other_names": ["ephrin receptor EphB4", "ephrin type-B receptor 4", "hepatoma transmembrane kinase", "tyrosine-protein kinase TYRO11", "tyrosine-protein kinase receptor HTK"], "pantherdb": {"HGNC": "3395", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "104757", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 10090, "uniprot_kb": "P54761"}, {"RGD": "1583193", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 10116, "uniprot_kb": "M0RDA4"}, {"ZFIN": "ZDB-GENE-100922-51", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "F1QU92"}, {"ZFIN": "ZDB-GENE-990415-62", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "O73875"}, {"ZFIN": "ZDB-GENE-990415-65", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "O73878"}, {"ZFIN": "ZDB-GENE-990415-60", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "O13147"}, {"Ensembl": "ENSDARG00000103576", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "A0A0G2L6L8"}, {"ZFIN": "ZDB-GENE-070713-2", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "A0A2R8QJW7"}, {"WormBase": "WBGene00006868", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 6239, "uniprot_kb": "O61460"}, {"FlyBase": "FBgn0025936", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 7227, "uniprot_kb": "Q9V4E5"}], "uniprot_kb": "P54760"}, "pathway": {"kegg": {"id": "hsa04360", "name": "Axon guidance - Homo sapiens (human)"}, "netpath": {"id": "Pathway_EGFR1", "name": "EGFR1"}, "pid": [{"id": "ephbfwdpathway", "name": "EPHB forward signaling"}, {"id": "ephrinbrevpathway", "name": "Ephrin B reverse signaling"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-2682334", "name": "EPH-Ephrin signaling"}, {"id": "R-HSA-2682334", "name": "EPH-Ephrin signaling"}, {"id": "R-HSA-3928662", "name": "EPHB-mediated forward signaling"}, {"id": "R-HSA-3928662", "name": "EPHB-mediated forward signaling"}, {"id": "R-HSA-3928664", "name": "Ephrin signaling"}, {"id": "R-HSA-3928664", "name": "Ephrin signaling"}, {"id": "R-HSA-3928665", "name": "EPH-ephrin mediated repulsion of cells"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}], "wikipathways": [{"id": "WP2877", "name": "Vitamin D Receptor Pathway"}, {"id": "WP4331", "name": "Neovascularisation processes"}, {"id": "WP4564", "name": "Neural Crest Cell Migration during Development"}, {"id": "WP4565", "name": "Neural Crest Cell Migration in Cancer"}]}, "pdb": ["2BBA", "2E7H", "2HLE", "2QKQ", "2VWU", "2VWV", "2VWW", "2VWX", "2VWY", "2VWZ", "2VX0", "2VX1", "2X9F", "2XVD", "2YN8", "3ZEW", "4AW5", "4BB4", "6FNI", "6FNJ", "6FNK", "6FNL", "6FNM"], "pfam": ["PF00041", "PF00536", "PF01404", "PF07699", "PF07714", "PF14575", "PF07647"], "pharmgkb": "PA27827", "pharos": {"target_id": 2880, "tdl": "Tchem"}, "pir": "A54092", "prosite": ["PS50011", "PS50105", "PS50853", "PS51550"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248983", "relationship": "is"}, {"id": "GNF248984", "relationship": "is"}, {"id": "GNF248985", "relationship": "is"}, {"id": "GNF248986", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF046644", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082170", "relationship": "is"}, {"id": "GNF082171", "relationship": "is"}, {"id": "GNF082172", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052812", "relationship": "is"}, {"id": "GNF057578", "relationship": "is"}, {"id": "GNF072681", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071589", "relationship": "is"}, {"id": "GNF071590", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF166260", "relationship": "is"}, {"id": "GNF166261", "relationship": "is"}, {"id": "GNF166262", "relationship": "is"}, {"id": "GNF166263", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF004221", "relationship": "is"}, "Invitrogen_IVTHSSIPKv2": [{"id": "GNF323794", "relationship": "is"}, {"id": "GNF323795", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF338518", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF093051", "relationship": "is"}, {"id": "GNF132749", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000007.14", "NC_060931.1", "NG_052671.1"], "protein": ["NP_004435.3", "XP_016867305.1", "XP_054213436.1"], "rna": ["NM_004444.5", "XM_017011816.2", "XM_054357461.1"], "translation": [{"protein": "XP_054213436.1", "rna": "XM_054357461.1"}, {"protein": "NP_004435.3", "rna": "NM_004444.5"}, {"protein": "XP_016867305.1", "rna": "XM_017011816.2"}]}, "reporter": {"HG-U133_Plus_2": ["202894_at", "216680_s_at"], "HG-U95Av2": "1351_at", "HTA-2_0": "TC07001677.hg.1", "HuEx-1_0": "3064293", "HuGene-1_1": "8141625", "HuGene-2_1": "17060758"}, "summary": "Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. [provided by RefSeq, Jul 2008].", "symbol": "EPHB4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414431"}, "unigene": "Hs.437008", "uniprot": {"Swiss-Prot": "P54760", "TrEMBL": ["Q541P7", "Q96L35"]}, "wikipedia": {"url_stub": "EPH receptor B4"}}